← Back to Search

Enteral Feeding Tube Accessory

Accessory for Feeding Tube Complications (SSA Trial)

N/A
Waitlist Available
Led By Eric Yudelevich, MD
Research Sponsored by Eric Yudelevich
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6 visit
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new device for feeding tubes aimed at preventing leaks in patients with long-term feeding tubes. The device attaches to the tube and reduces leaks and friction at the insertion site, potentially improving comfort and reducing infection risk.

Who is the study for?
This trial is for adults aged 22 to 85 who have had a gastrostomy or jejunostomy feeding tube for at least 3 months and are scheduled for a tube replacement. Participants must understand the study, consent in writing, be able to take their temperature as required, and commit to follow-up procedures. Excluded are those needing sedation for tube changes, non-English speakers, pregnant women, people allergic to silicone, steroid or immunosuppressant users, recent participants in other trials, those unable to self-report or perform self-care.
What is being tested?
The trial tests a new stoma site accessory designed by Cleveland Clinic intended to prevent leakage around long-term feeding tubes. It's being compared with standard care during routine feeding tube replacements. The accessory is similar to FDA-approved components used with gastrostomy and jejunostomy tubes.
What are the potential side effects?
Potential side effects may include skin irritation or allergic reactions at the stoma site due to contact with the accessory material (medical-grade silicone), infection risks associated with any procedure involving enteral feeding tubes, and discomfort related to the placement of the new device.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6 visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of feeding tube complications for each patient with a study accessory
Successful Accessory placement
Secondary study objectives
Characteristics of Pain and Leakage
Characteristics of Pain and Leakage Questionnaire
Quality of Life PROMIS 10 questionnaire
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Stoma Site AccessoryExperimental Treatment1 Intervention
Stoma site accessory with enteral tube replacement procedure.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for feeding tube complications, such as abdominal wall leakage, include the use of stoma site accessories, proper tube placement techniques, and the application of barrier creams or dressings. Stoma site accessories, like the one studied in the trial, are designed to create a better seal around the feeding tube, preventing leakage by providing a snug fit and reducing movement. Proper tube placement ensures that the tube is correctly positioned to minimize irritation and leakage. Barrier creams and dressings protect the skin around the stoma from moisture and irritation, promoting healing and preventing infection. These treatments are crucial for patients as they help maintain the integrity of the stoma site, reduce the risk of infection, and improve overall comfort and quality of life.
Percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer.

Find a Location

Who is running the clinical trial?

Eric YudelevichLead Sponsor
Eric Yudelevich, MDPrincipal InvestigatorThe Cleveland Clinic
~3 spots leftby Nov 2025